Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ureteral Neoplasms × Plasma Exchange × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 2 Acute Kidney Injury 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Rare Diseases 1 Paraproteinemias 1 Neuromyelitis Optica 1 Neurologic Manifestations 1 Nervous System Diseases 1 Neoplasms, Plasma Cell 1 Myelitis, Transverse 1 Multiple Sclerosis 1 Mental Disorders 1 Kidney Diseases 1 Hematologic Diseases 1 Encephalomyelitis, Acute Disseminated 1 Diffuse Cerebral Sclerosis of Schilder 1 Autoimmune Diseases 1

Interventions

Gemcitabine 11 Specimen Handling 9 pembrolizumab 7 enfortumab vedotin 7 Magnetic Resonance Spectroscopy 7 Cisplatin 7 Carboplatin 5 vinflunine 4 avelumab 4 Immunoglobulin G 3 Disulfides 3 Biopsy 3 eribulin 2 cabozantinib 2 atezolizumab 2 Standard of Care 2 Ramucirumab 2 Radiotherapy 2 Platinum 2 Nivolumab 2 Nephroureterectomy 2 Ipilimumab 2 Docetaxel 2 CTLA-4 Antigen 2 Bortezomib 2 1,2-diaminocyclohexaneplatinum II citrate 2 vandetanib 1 tremelimumab 1 tocilizumab 1 tamibarotene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07087860 2025-12-09

RECIPE-B1

Mayo Clinic

Phase 2 Recruiting

Urinary Bladder Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡